ArticleThe Journal of infectious diseases2026

Resistance Analysis of Low-Level Virologic Rebound During HIV-1 Treatment With Lenacapavir and Broadly Neutralizing Antibodies Teropavimab and Zinlirvimab.

Lisa Selzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.